Next Article in Journal
Rational Development of a Carrier-Free Dry Powder Inhalation Formulation for Respiratory Viral Infections via Quality by Design: A Drug-Drug Cocrystal of Favipiravir and Theophylline
Next Article in Special Issue
Long-Term Stability Prediction for Developability Assessment of Biopharmaceutics Using Advanced Kinetic Modeling
Previous Article in Journal
Inhibition of Escherichia Virus MS2, Surrogate of SARS-CoV-2, via Essential Oils-Loaded Electrospun Fibrous Mats: Increasing the Multifunctionality of Antivirus Protection Masks
Previous Article in Special Issue
Constant Voltage Iontophoresis Technique to Deliver Terbinafine via Transungual Delivery System: Formulation Optimization Using Box–Behnken Design and In Vitro Evaluation
 
 
Article

Article Versions Notes

Pharmaceutics 2022, 14(2), 304; https://doi.org/10.3390/pharmaceutics14020304
Action Date Notes Link
article pdf uploaded. 27 January 2022 12:53 CET Version of Record https://www.mdpi.com/1999-4923/14/2/304/pdf-vor
article supplementary file uploaded. 2 February 2022 15:30 CET - https://www.mdpi.com/1999-4923/14/2/304#supplementary
article xml file uploaded 10 February 2022 10:46 CET Original file -
article xml uploaded. 10 February 2022 10:46 CET Update -
article pdf uploaded. 10 February 2022 10:46 CET Updated version of record https://www.mdpi.com/1999-4923/14/2/304/pdf-vor
article html file updated 10 February 2022 11:17 CET Original file -
article xml file uploaded 17 February 2022 10:24 CET Update -
article xml uploaded. 17 February 2022 10:24 CET Update https://www.mdpi.com/1999-4923/14/2/304/xml
article pdf uploaded. 17 February 2022 10:24 CET Updated version of record https://www.mdpi.com/1999-4923/14/2/304/pdf
article html file updated 17 February 2022 10:39 CET Update -
article html file updated 17 February 2022 10:39 CET Update -
article html file updated 31 July 2022 06:48 CEST Update https://www.mdpi.com/1999-4923/14/2/304/html
Back to TopTop